Stage I non-small cell lung cancer (NSCLC)

Clinical significance of lymphatic vessel invasion in stage I non-small cell lung cancer patients

K. F. Ma, Chu, X. Y., and Liu, Y., Clinical significance of lymphatic vessel invasion in stage I non-small cell lung cancer patients, vol. 14, pp. 1819-1827, 2015.

The aim of this retrospective study was to evaluate the prognostic influence of lymphatic vessel invasion (LVI) in stage I non-small cell lung cancer (NSCLC) patients. From January 2004 to December 2007, LVI was detected in 57 patients with T1N0M0 NSCLC; therefore, 114 patients with the same pathology, T stage, and surgery method, but without LVI, were selected as the control group to compare survival. The overall survival and relapse-free survival rates were estimated using the Kaplan-Meier method, log-rank test, and Cox proportional hazards analysis.

Subscribe to Stage I non-small cell lung cancer (NSCLC)